---
document_datetime: 2025-10-21 11:16:45
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/piasky-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: piasky-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 14.3873041
conversion_datetime: 2025-12-22 00:26:12.401633
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Piasky

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | This was an application for a group of | 17/10/2025                          |                                             | SmPC, Annex                      |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000296137   | II and PL   |
|---------------------|-------------|

<div style=\"page-break-after: always\"></div>

|                                       | (PSUSA/00011071/202502) Piasky. The English wording was agreed by the PRAC but the translations were not reviewed. C.I.11.z To update the RMP of Piasky 340mg/2ml solution for injection/infusion to version 2.0 to remove the Controlled Access Program. The summary of changes have been agreed by the PRAC in the PRAC recommendation, for the PSUSA (PSUSA/00011071/202502). C.I.3.z To update Section 4.4 of the SmPC to include a statement on the educational materials (including annual reminders) addressed to healthcare professionals which clearly and succinctly explains the purpose and scope of the materials in order to comply with the EMA Guideline on the SmPC and Guideline on good pharmacovigilance practices (GVP) - Module XVI - Risk minimisation measures (Rev 3) (EMA/204715/2012 Rev 3 of 26 July 2024). Section 2 of the package leaflet is   |            |                        |             |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------------------|-------------|
| Variation type IB / EMA/VR/0000262158 | B.II.f.1 Change in the shelf-life or storage conditions of the finished product - B.II.f.1.d Change in storage conditions of the finished product or the diluted/reconstituted product - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 25/04/2025 | SmPC, Labelling and PL |             |
| PSUR / EMA/PSUR/0000268996            | - -                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |                        | Maintenance |

<div style=\"page-break-after: always\"></div>